Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
Holding SCNI?
Track your performance easily
Earnings Data
Report Date
May 29, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2018
|% Change Since: 16.56%
|Next Earnings Date:Aug 22, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there were notable achievements such as the reduction in net loss, positive regulatory feedback, and growth in the CDMO business, there were also challenges like a significant decrease in cash position and negative shareholder equity. The sentiment is balanced with both opportunities and financial restructuring challenges.Company Guidance
In the Q2 2024 earnings call for Scinai Immunotherapeutics, CEO Amir Reichman provided detailed guidance on the company's strategic objectives and financial outlook. Scinai aims to fast-track IL-17 development to toxicology studies and increase CDMO business unit sales to $1.25 million. The company plans to reduce R&D risks by partnering with other pharma companies while maintaining careful spending to control its burn rate. Financially, Scinai reported a net loss of $4.48 million for the first half of 2024, a decrease from $7.28 million in the same period in 2023, attributed to reduced operating expenses. In addition, Scinai is working on a debt-to-equity restructuring deal expected to positively impact shareholder equity by approximately $19 million. The company also announced a $2 million equity commitment from Daniel Stone, which will provide additional financial flexibility. Overall, the guidance highlights Scinai's focus on advancing its R&D pipeline and CDMO business while ensuring financial stability and growth.Reduction in Operating Expenses
R&D expenses decreased to $2.79 million compared to $3.45 million the previous year, and marketing and G&A expenses were reduced to $1 million from $2.3 million the previous year.
Net Loss Reduction
Net loss for the first 6 months of 2024 was reduced to $4.48 million compared to $7.28 million in the first 6 months of 2023.
Positive Regulatory Feedback
Received positive regulatory feedback from the Paul Erlich Institute for their drug development program towards Phase I/IIa clinical trial of their anti-IL-17 AF nanoAb in plaque psoriasis.
CDMO Business Growth
CDMO unit generated work orders valued at $600,000 from 5 clients since January 2024 with a 2024 guidance of $1.25 million.
Private Equity Commitment
Received a $2 million equity commitment from Daniel Stone through RK Stone Miami LLC, with the commitment valid until December 31, 2024.
---
SCNI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SCNI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 22, 2024 | $3.02 | $3.54 | +17.22% |
| Aug 15, 2024 | $3.70 | $3.77 | +1.89% |
| Jul 02, 2024 | $2.94 | $2.98 | +1.36% |
| Apr 30, 2024 | $4.44 | $4.55 | +2.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Scinai Immunotherapeutics (SCNI) report earnings?
Scinai Immunotherapeutics (SCNI) is schdueled to report earning on May 29, 2025, TBA Not Confirmed.
What is Scinai Immunotherapeutics (SCNI) earnings time?
Scinai Immunotherapeutics (SCNI) earnings time is at May 29, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SCNI EPS forecast?
Currently, no data Available
---